Evidence map›Paper›PMID 25733714›Full record

ArticleThe Journal of cell biology2015

Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells.

Ralph Zellweger, Damian Dalcher, Karun Mutreja, Matteo Berti, Jonas A Schmid, Raquel Herrador, Alessandro Vindigni, Massimo Lopes

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 465 papers.

0numbers the graph read from it
0cells of the map it votes in
465citing papers in PubMed
28.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

465 citing papers in PubMed, 677 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

405 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ralph ZellwegerInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Damian DalcherInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Karun MutrejaInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Matteo BertiDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104.
Jonas A SchmidInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Raquel HerradorInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
Alessandro VindigniDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104.
Massimo LopesInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland lopes@imcr.uzh.ch.
University of Zurich · CHSaint Louis University · US

Funding

New Mechanisms of Replication Stress ResponseR01GM108648 · NIGMS · SAINT LOUIS UNIVERSITY · PI VINDIGNI, ALESSANDRO · 2014 to 2018
$1.4M
NIGMS NIH HHS R01 GM108648NIGMS NIH HHS R01GM108648
6 · The paper itself

Abstract

Replication fork reversal protects forks from breakage after poisoning of Topoisomerase 1. We here investigated fork progression and chromosomal breakage in human cells in response to a panel of sublethal genotoxic treatments, using other topoisomerase poisons, DNA synthesis inhibitors, interstrand cross-linking inducers, and base-damaging agents. We used electron microscopy to visualize fork architecture under these conditions and analyzed the association of specific molecular features with checkpoint activation. Our data identify replication fork uncoupling and reversal as global responses to genotoxic treatments. Both events are frequent even after mild treatments that do not affect fork integrity, nor activate checkpoints. Fork reversal was found to be dependent on the central homologous recombination factor RAD51, which is consistently present at replication forks independently of their breakage, and to be antagonized by poly (ADP-ribose) polymerase/RECQ1-regulated restart. Our work establishes remodeling of uncoupled forks as a pivotal RAD51-regulated response to genotoxic stress in human cells and as a promising target to potentiate cancer chemotherapy.

Indexed as

DNA DamageDNA ReplicationCell Line, TumorHEK293 CellsHumansPoly(ADP-ribose) PolymerasesRad51 RecombinaseRecQ HelicasesTopoisomerase InhibitorsPoly(ADP-ribose) PolymerasesRAD51 protein, humanRad51 RecombinaseRecQ HelicasesRECQL protein, humanTopoisomerase Inhibitors

Identifiers

PMID25733714
PMCPMC4347635
OpenAlexW2104584181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.